High Prevalence of Antibodies to the gp120 V3 Region Principal Neutralizing Determinant of HIV-1MNin Sera from Africa and the Americas
- 1 October 1991
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 7 (10) , 831-838
- https://doi.org/10.1089/aid.1991.7.831
Abstract
Neutralizing antibodies (NA) against HIV-1MN and HIV-1IIIB, and antibodies binding to synthetic peptides (BA) derived from the gp120 envelope V3 region principal neutralizing determinants (PND) of the HIV-1MN, HIV-1IIIB, and HIV-1Z3 virus strains were assayed in HIV-1 antibody-positive sera from the United States, Haiti, Brazil, Zaire, and Zimbabwe. The ability of soluble PND peptide to block neutralization of the corresponding virus by representative sera was also tested. In each country, NA and BA titers were highest against the HIV-1MN strain, and compared with other countries, NA and BA titers against HIV-1MN were higher in sera from the United States and Haiti. When NA titers were compared with BA titers against either HIV-1MN or HIV-1IIIB, no correlation was found for the HIV-1IIIB strain, but there was a significant correlation for HIV-1MN. Addition of the HIV-1MN strain peptide to a neutralization assay for HIV-1MN resulted in a four- to tenfold reduction in NA titers in sera from the United States, Zaire, and Brazil. The results suggest that HIV-1MN and closely related variants are prevalent in many parts of the world, and that antibodies directed against the PND account for most of the neutralizing activity in sera of infected individuals.Keywords
This publication has 46 references indexed in Scilit:
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)Molecular Immunology, 1990
- C-Terminal Fragments of gpl20 and Synthetic Peptides from Five HTLV-III Strains: Prevalence of Antibodies to the HTLV-III-MN Isolate in Infected IndividualsAIDS Research and Human Retroviruses, 1990
- Cross-Neutralizing Antibodies Against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a New Isolate SBL-K135)AIDS Research and Human Retroviruses, 1989
- Specificity and Function of the Individual Amino Acids of an Important Determinant of Human Immunodeficiency Virus Type 1 that Induces Neutralizing ActivityJournal of General Virology, 1989
- An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodiesNature, 1989
- Antibodies from Human Immunodeficiency Virus-Infected Individuals Bind to a Short Amino Acid Sequence that Elicits Neutralizing Antibodies in AnimalsAIDS Research and Human Retroviruses, 1989
- Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzeesVaccine, 1988
- Use of a Sensitive Neutralization Assay to Measure the Prevalence of Antibodies to the Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1988
- Characterization of Serum Netralization Response to the Human Immunodeficiency Virus (HIV)AIDS Research and Human Retroviruses, 1987